Evommune, Inc. (EVMN) — Financial Flexibility Index
Evommune, Inc. (EVMN) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-16.59 Million (operating CF $-16.70 Million minus capex $104.00K) represents -1% of total liabilities ($19.38 Million). Check EVMN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Evommune, Inc. Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Evommune, Inc. across 3 annual periods. See Evommune, Inc. (EVMN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Evommune, Inc. (2023–2025)
Year-by-year free cash flow to debt coverage for Evommune, Inc.. For the full company profile including market capitalisation, see EVMN market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.93x | $-76.21 Million | $-76.44 Million | $19.38 Million | ▼ -1390.8% |
| 2024 | -0.26x | $-58.11 Million | $-58.20 Million | $220.29 Million | ▼ -41.3% |
| 2023 | -0.19x | $-29.85 Million | $-29.97 Million | $159.96 Million | — |